Results 261 to 270 of about 519,424 (339)

The Impact of Tirabrutinib Monotherapy for the Treatment of Bing‐Neel Syndrome: A Multicenter Retrospective Study

American Journal of Hematology, EarlyView.
Masuho Saburi, Taro Masunari, Noriko Fukuhara, Yuichiro Inagaki, Arika Shimura, Naoto Imoto, Yuta Hasegawa, Masao Hagihara, Nobuhiko Kobayashi, Hanae Kumekawa, Hideyuki Nakazawa, Kana Miyazaki, Toshiro Kawakita, Takahiro Isshiki, Atsushi Katsube, Shin Fujisawa, Yuichi Horigome, Yusuke Koba, Fumiaki Jinnouchi, Naohiro Sekiguchi   +19 more
wiley   +1 more source

Unusual peripheral T-cell lymphoma with a cytotoxic phenotype presenting in the pancreas. [PDF]

Ann Hematol
Dubois J, Bellal S, Copin MC, Mallet-Guy P, Bouron C, Lannes A, Tanguy-Schmidt A, Hunault-Berger M, Paillassa J.   +8 more
europepmc   +1 more source

Challenges in defining the immune microenvironment in T-cell lymphoma. [PDF]

Haematologica
Dogan A, Roshal M.
europepmc   +1 more source

Hemophagocytic syndrome associated with nasal T-cell lymphoma: Report of an autopsy case.

, 1988
Kazue Takai, Masayoshi Sanada, Keiichi Honma, Etsuo Okazaki   +3 more
openalex   +2 more sources

Expert Perspective: Diagnosis and Treatment of Castleman Disease

Arthritis &Rheumatology, Accepted Article.
Summary Castleman disease (CD) is a major diagnostic challenge for Rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Luke Y.C. Chen, Lu Zhang, David C. Fajgenbaum   +2 more
wiley   +1 more source

Angioimmunoblastic T-cell lymphoma: a concise overview encompassing the pathogenetic, pathological, clinical, therapeutical characteristics, and recent advances. [PDF]

Clin Exp Med
Feng Y, Ma Y, Li T, Liu M, Hong Z, Yin Q, Zheng M.   +6 more
europepmc   +1 more source

Approaches to repurposing reverse transcriptase antivirals in cancer

British Journal of Clinical Pharmacology, EarlyView.
This review highlights the role of reverse transcriptase (RT) inhibition in cellular regulation associated with non‐terminal repeat retrotransposons and endogenous retroviruses. Based on their pleiotropic characteristics, RT inhibitors (RTIs) are discussed as potential anticancer agents.
Richard Head, Saiful Islam, Jennifer H. Martin   +2 more
wiley   +1 more source

Cutaneous epitheliotropic T-cell lymphoma in a sugar glider (Petaurus breviceps). [PDF]

Vet Dermatol
Amati P, Dedola C, Demontis R, Brachelente C.   +3 more
europepmc   +1 more source

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada

British Journal of Clinical Pharmacology, EarlyView.
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley   +1 more source

EZH2 inhibitor SHR2554 enhances the anti-tumor efficacy of HDAC inhibitor Chidamide through STAT1 in T-cell lymphoma. [PDF]

Cell Death Dis
Wu J, Hu D, Yu H, Wang D, Ye Y, Cao J, Pan T, Mi L, Song Y, Wu M, Ping L, Zhu J.   +11 more
europepmc   +1 more source